Synergistic induction of cyclin D1 in oligodendrocyte progenitor cells by IGF-I and FGF-2 requires differential stimulation of multiple signaling pathways

GLIA

Volumn 55, Issue 10, 2007, Pages 1011-1022

  Frederick, Terra J ^a,b,c   Min, Jungsoo ^a,b   Altieri, Stefanie C ^a,b   Mitchell, Nina E ^a,b   Wood, Teresa L ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cell cycle; GSK 3 ; Neural development; Nuclear localization; PI3 kinase; Proliferation; Signal transduction

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STIMULATION; CONTROLLED STUDY; NEWBORN; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STEM CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANIMALS, NEWBORN; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLINS; DRUG SYNERGISM; FIBROBLAST GROWTH FACTOR 2; GLYCOGEN SYNTHASE KINASE 3; INSULIN-LIKE GROWTH FACTOR I; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; OLIGODENDROGLIA; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STEM CELLS; UP-REGULATION;

EID: 34447521578     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20520     Document Type: Article

References (42)

1. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270:23589-23597.
2. Alt JR, Cleveland JL, Hannink M, Diehl JA. 2000. Phosphorylation- dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 14:3102-3114.
3. Bansal R, Kumar M, Murray K, Morrison RS, Pfeiffer SE. 1996. Regulation of FGF receptors in the oligodendrocyte lineage. Mol Cell Neurosci 7:263-275.
4. Bansal R, Magge S, Winkler S. 2003. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells. J Neurosci Res 74:486-493.
5. Baron W, Metz B, Bansal R, Hoekstra D, deVries H. 2000. PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: Regulation of proliferation and differentiation by multiple intracellular signaling pathways. Mol Cell Neurosci 15:314-329.
6. Barres B, Schmid R, Sendtner M, Raff M. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283-295.
7. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC. 1992. Cell death in the oligodendrocyte lineage. J Neurobiol 23:1221-1230.
8. Bhat NR, Zhang P. 1996. Activation of mitogen-activated protein kinases in oligodendrocytes. J Neurochem 66:1986-1994.
9. Butler AA, Yakar S, Gewolb IH, Karas M, Okubo Y, LeRoith D. 1998. Insulin-like growth factor-I receptor signal transduction: At the interface between physiology and cell biology. Comp Biochem Physiol 121:19-26.
10. Cohen RI, Marmur R, Norton WT, Mehler MF, Kessler JA. 1996. Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes. J Neurosci 16:6433-6442.
11. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789.
12. Diehl JA, Cheng M, Roussel MF, Sherr CJ. 1998. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499-3511.
13. Ebner S, Dunbar M, McKinnon RD. 2000. Distinct roles for PI3K in proliferation and survival of oligodendrocyte progenitor cells. J Neurosci Res 62:336-345.
14. Frederick TJ, Wood TL. 2004. IGF-I and FGF-2 coordinately enhance cyclin D1 and cyclin E-cdk2 association and activity to promote G(1) progression in oligodendrocyte progenitor cells. Mol Cell Neurosci 25:480-492.
15. Ghiani C, Gallo V. 2001. Inhibition of cyclin E-cyclin-dependent kinase 2 complex formation and activity is associated with cell cycle arrest and withdrawal in oligodendrocyte progenitor cells. J Neurosci 21:1274-1282.
16. Huang Z, Tang XM, Cambi F. 2002. Down-regulation of the retinoblastoma protein (rb) is associated with rat oligodendrocyte differentiation. Mol Cell Neurosci 19:250-262.
17. Jiang F, Frederick TJ, Wood TL. 2001. IGF-I synergizes with FGF-2 to stimulate oligodendrocyte progenitor entry into the cell cycle. Dev Biol 232:414-423.
18. Johnson JR, Chu AK, Sato-Bigbee C. 2000. Possible role of CREB in the stimulation of oligodendrocyte precursor cell proliferation by neurotrophin-3. J Neurochem 74:1409-1417.
19. Khorchid A, Larocca JN, Almazan G. 1999. Characterization of the signal transduction pathways mediating noradrenaline-stimulated MAPK activation and c-fos expression in oligodendrocyte progenitors. J Neurosci Res 58:765-778.
20. Larocca JN, Almazan G. 1997. Acetylcholine agonists stimulate mitogen-activated protein kinase in oligodendrocyte progenitors. J Neurosci Res 50:743-754.
21. LeRoith D, Roberts CT Jr. 2003. The insulin-like growth factor system and cancer. Cancer Lett 195:127-137.
22. LeRoith D, Werner H, Beitner-Johnson D, Roberts CJ. 1995. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163.
23. Levison S, McCarthy K. 1991.Astroglia in culture. In: Banker G, Goslin K, editors. Culturing nerve cells. Cambridge: MIT. pp 309-336.
24. McCarthy K, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
25. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R, Alessi DR. 2005. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J 24:1571-1583.
26. Ness JK, Mitchell NE, Wood TL. 2002. IGF-I and NT-3 signaling pathways in developing oligodendrocytes: Differential regulation and activation of receptors and the downstream effector Akt. Dev Neurosci 24:437-445.
27. Ness JK, Scaduto RC Jr, Wood TL. 2004. IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors. Glia 46:183-194.
28. Ness JK, Wood TL. 2002. Insulin-like growth factor I, but not neurotrophin-3, sustains Akt activation and provides long-term protection of immature oligodendrocytes from glutamate-mediated apoptosis. Mol Cell Neurosci 20:476-488.
29. Nishiyama A. 2007. Polydendrocytes: NG2 cells with many roles in development and repair of the CNS. Neuroscientist 13:62-76.
30. Nishiyama A, Watanabe M, Yang Z, Bu J. 2002. Identity, distribution, and development of polydendrocytes: NG2-expressing glial cells. J Neurocytol 31:437-455.
31. Petley T, Graff K, Jiang W, Yang H, Florini J. 1999. Variation among cell types in the signaling pathways by which IGF-1 stimulates specific cellular responses. Horm Metab Res 31:70-75.
32. Ramakrishnan M, Musa NL, Li J, Liu PT, Pestell RG, Hershenson MB. 1998. Catalytic activation of extracellular signal-regulated kinases induces cyclin D1 expression in primary tracheal myocytes. Am J Respir Cell Mol Biol 18:736-740.
33. Ravenhall C, Guida E, Harris T, Koutsoubos V, Stewart A. 2000. The importance of ERK activity in the regulation of cyclin D1 levels and DNA synthesis in human cultured airway smooth muscle. Br J Pharmacol 131:17-28.
34. Rechler MM, Nissley SP. 1985. The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol 47:425-442.
35. Saito Y, Vandenheede JR, Cohen P. 1994. The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells. Biochem J 303 (Part 1):27-31.
36. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163.
37. Tang DG, Tokumoto YM, Apperly JA, Lloyd AC, Raff MC. 2001. Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science 291:868-871.
38. Vemuri G, McMorris F. 1996. Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival. Development 122:2529-2537.
39. Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B, Pestell RG. 1998. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol 18:3212-3222.
40. Ye P, D'Ercole AJ. 1999. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-α-induced injury. Endocrinology 140:3063-3072.
41. Yim SH, Hammer JA, Quarles RH. 2001. Differences in signal transduction pathways by which platelet-derived and fibroblast growth factors activate extracellular signal-regulated kinase in differentiating oligodendrocytes. J Neurochem 76:1925-1934.
42. Young G, Levison S. 1997. An improved method for propagating oligodendrocyte progenitors in vitro. J Neurosci Methods 77:163-168.